Myriad Genetics, Inc. Company Profile

16:43 EDT 25th September 2018 | BioPortfolio

Myriad Genetics, Inc. is a biotechnology company focused on the development and marketing of novel therapeutic and molecular diagnostic products. Myriad's news and other information are available on the Company's Web site at BRACAnalysis(R) is a registered trademark of Myriad Genetics, Inc. in the U.S. and other countries.

News Articles [444 Associated News Articles listed on BioPortfolio]

Myriad Genetics Signs Definitive Agreement to Acquire Counsyl

Myriad Genetics (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it has signed a definitive agreement to acquire Counsyl, a pioneer in expanded carrier...

Counsyl to be acquired by Myriad Genetics in $375M deal

A deal has been reached by Myriad Genetics to pay about $375 million for genetic testing and DNA analysis services provider C -More- 

Myriad Reports Approval For BRACAnalysis Diagnostic System In Japan

LONDON (dpa-AFX) - Myriad Genetic Laboratories, Inc., a subsidiary of Myriad Genetics, Inc. (MYGN), announced the Japanese Ministry of Health, Labour, and Welfare has granted manufacturing and mar...

Pomerantz LLP: SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - MYGN

NEW YORK, NY / ACCESSWIRE / April 25, 2018 / Pomerantz LLP announces that a class action lawsuit has been filed against Myriad Genetics, Inc. ("Myriad" or the "Company") (NASDAQ: MYGN) and certain ...

Myriad Genetics acquires reproductive testing firm Counsyl for $375mm in cash and stock

Myriad Genetics Inc. agreed to acquire privately held Counsyl Inc., a DNA screening company focused on prenatal testing, women's health, and hereditary disorders.

Myriad Genetics to acquire health technology company, Counsyl for $375 million

Myriad Genetics, Inc., a leader in molecular diagnostics and personalised medicine, has signed a definitive agreement to acquire Counsyl, a pioneer in expanded carrier screening and non─invasive pre...

INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Class Action Lawsuit Filed Against Myriad Genetics, Inc. - MYGN

RADNOR, PA / ACCESSWIRE / May 29, 2018 / The law firm of Kessler Topaz Meltzer & Check, LLP reminds Myriad Genetics, Inc. (NASDAQ: MYGN) ("Myriad") investors that a class action lawsuit has been fi...

Contrasting Nymox Pharmaceutical

Nymox Pharmaceutical and Myriad Genetics are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings,...

Drugs and Medications [0 Results]


Clinical Trials [348 Associated Clinical Trials listed on BioPortfolio]

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Virtual Reality Intervention in Cancer Genetics

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel p...

Genetics Tests : How to Improve Management Within Two Medical Specialities

This survey will assess discrepancies between official clinical genetics guidelines and practices within 3 West regions of France.

Genetics of Asthma and Bronchial Hyperresponsiveness

To investigate the genetics of asthma by reexamining a carefully characterized population of patients with asthma, and by studying their families.

Companies [63 Associated Companies listed on BioPortfolio]

Myriad Genetics, Inc.

Myriad Genetics, Inc. is a biotechnology company focused on the development and marketing of novel therapeutic and molecular diagnostic products. Myriad's news and other information are available on t...

Myriad House

PR Week ranks Myriad as a UK top 150 PR agency and as number one in Cambridgeshire and across the East of England region. One of the country’s leading healthcare agencies, and among the largest...

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent ce...

More Information about "Myriad Genetics, Inc." on BioPortfolio

We have published hundreds of Myriad Genetics, Inc. news stories on BioPortfolio along with dozens of Myriad Genetics, Inc. Clinical Trials and PubMed Articles about Myriad Genetics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Myriad Genetics, Inc. Companies in our database. You can also find out about relevant Myriad Genetics, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record